SYN-Tech Chem & Pharm Co Ltd - Asset Resilience Ratio
SYN-Tech Chem & Pharm Co Ltd (1777) has an Asset Resilience Ratio of 0.42% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is SYN-Tech Chem & Pharm Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2022)
This chart shows how SYN-Tech Chem & Pharm Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SYN-Tech Chem & Pharm Co Ltd (1777) total assets.
Liquid Assets Composition Over Time
This chart breaks down SYN-Tech Chem & Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of SYN-Tech Chem & Pharm Co Ltd to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$12.09 Million | 0.42% |
| Total Liquid Assets | NT$12.09 Million | 0.42% |
Asset Resilience Insights
- Limited Liquidity: SYN-Tech Chem & Pharm Co Ltd maintains only 0.42% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SYN-Tech Chem & Pharm Co Ltd Industry Peers by Asset Resilience Ratio
Compare SYN-Tech Chem & Pharm Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
CSL Ltd
AU:CSL |
Biotechnology | 0.41% |
|
Vaxcyte Inc
NASDAQ:PCVX |
Biotechnology | 41.54% |
|
Bachem Holding AG
SW:BANB |
Biotechnology | 0.00% |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX |
Biotechnology | 38.51% |
|
Chongqing Zhifei Bio Products
SHE:300122 |
Biotechnology | -0.08% |
|
HLB Co. Ltd
KQ:028300 |
Biotechnology | 3.29% |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
Biotechnology | 2.30% |
|
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
Biotechnology | 0.12% |
Annual Asset Resilience Ratio for SYN-Tech Chem & Pharm Co Ltd (2015–2022)
The table below shows the annual Asset Resilience Ratio data for SYN-Tech Chem & Pharm Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 4.29% | NT$119.16 Million ≈ $3.75 Million |
NT$2.78 Billion ≈ $87.57 Million |
-4.66pp |
| 2021-12-31 | 8.95% | NT$259.09 Million ≈ $8.16 Million |
NT$2.90 Billion ≈ $91.21 Million |
+0.64pp |
| 2019-12-31 | 8.31% | NT$154.60 Million ≈ $4.87 Million |
NT$1.86 Billion ≈ $58.63 Million |
-6.69pp |
| 2018-12-31 | 15.00% | NT$273.63 Million ≈ $8.62 Million |
NT$1.82 Billion ≈ $57.49 Million |
-5.77pp |
| 2017-12-31 | 20.77% | NT$323.16 Million ≈ $10.18 Million |
NT$1.56 Billion ≈ $49.02 Million |
+20.56pp |
| 2016-12-31 | 0.21% | NT$2.73 Million ≈ $85.85K |
NT$1.29 Billion ≈ $40.56 Million |
-4.53pp |
| 2015-12-31 | 4.74% | NT$58.00 Million ≈ $1.83 Million |
NT$1.22 Billion ≈ $38.57 Million |
-- |
About SYN-Tech Chem & Pharm Co Ltd
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more